Home | Merck Canada

Inventing for life

For over 130 years, Merck Canada has been providing leading innovations and therapies for many of our world’s most challenging diseases in pursuit of our mission to save and improve lives.

We use the power of leading-edge science to help save and improve lives around the world.

We’re following the science to tackle some of the world’s greatest health threats.

See how we’re making a difference

View our stories

Female medical practitioner reassuring a patient

Shared Decision Making: Taking an Active Role in Your Cancer Care Journey

A cancer diagnosis can be a life-altering and emotional event. Making important choices about your cancer journey can be complex and overwhelming, especially when decisions need to be made quickly.

Celebrating Diversity: Merck Canada Participates in Pride Toronto

This past June, Merck Canada participated in the Pride Toronto festivities. The entire celebration culminated on Sunday, June 25, with the main parade which featured nearly 90 Merck employees along with their friends and family. Dubbed internally as Merck’s Love Protest, our contingency proudly held up colourful signs that said, “Diversity is in our DNA,” […]

Understanding melanoma: Signs, symptoms and risk factors

Understanding melanoma: Signs, symptoms and risk factors Share this article What is melanoma? Melanoma is a very serious form of skin cancer because it can spread (metastasize) to other parts of the body. Characterized by the uncontrolled growth of melanocytes—the pigment-producing cells that gives skin, hair, and eyes their colour—melanoma is responsible for the vast […]

The Importance of Skin Checks: Encouraging Canadians to Practice Skintimacy™

Melanoma is the most invasive type of skin cancer with the highest risk of death.1 With an estimated 9,000 Canadians diagnosed in 2022,2 melanoma can present a serious health concern for Canadians.

How the Lung Diagnostic Assessment Program contributes to improving access to care for rural Ontarians with lung cancer

Lung Cancer Innovation Challenge In early 2021, Merck Canada, in partnership with MaRS Discovery District (MaRS), launched the Lung Cancer Innovation Challenge (LCIC) and asked Ontario-based innovators to identify, implement, and scale solutions that could help enhance the lung cancer patient journey, with the goal of reducing the length of time between diagnosis and treatment, and enabling improved health outcomes.

Early Detection: An Important Step in Cancer Care

Over 247,000 Canadians are expected to be diagnosed with cancer this year.1 Early detection of cancer, when it is often easier to treat, can help support better health outcomes.2 Some of the benefits of early detection include less aggressive forms of therapy3, as well as an increase in 5-year survival rates for some of the most common cancer types in Canada.

Research and Products

Where creativity meets research We bring creative minds together to invent important medicines and vaccines. We stop at nothing to help save and improve lives.

Learn More

Philanthropy

We support programs to help improve access to health and enhance the quality of life in our communities